The use of Ivermectin in treating Covid- 19: FOI release
- Published
- 19 October 2022
- Directorate
- Chief Medical Officer Directorate
- FOI reference
- FOI/202200316459
- Date received
- 8 August 2022
- Date responded
- 1 September 2022
Information request and response under the Freedom of Information (Scotland) Act 2002.
Information requested
“Has the directorate ever discussed the use of Ivermectin as a treatment for Covid-19 and if so what were the conclusions around its use in Scotland.“
Response
The answer to your question is: The Scottish Government’s Directorate of the Chief Medical Officer is working closely with colleagues in the UK Department of Health and Social Care and the UK regulatory body responsible for ensuring the licensing, safety and efficacy of all UK medicines, the Medicines and Healthcare products Regulatory Agency (MHRA), to prioritise potential treatments for COVID-19. Results of well-designed randomised controlled clinical trials exploring treatment efficacy of Ivermectin to treat COVID-19 are awaited. The MHRA, together with an independent advisory group, continues to review the emerging body of evidence regarding all potential medicines for treatment or prevention of COVID-19, including Ivermectin.
About FOI
The Scottish Government is committed to publishing all information released in response to Freedom of Information requests. View all FOI responses at http://www.gov.scot/foi-responses.
Contact
Please quote the FOI reference
Central Enquiry Unit
Email: ceu@gov.scot
Phone: 0300 244 4000
The Scottish Government
St Andrews House
Regent Road
Edinburgh
EH1 3DG
There is a problem
Thanks for your feedback